drugset
drugset / Trial / NCT03660436

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants

NCT03660436 ↗

Phase 1 Completed 131 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effects of experimental medication BMS-986165 in healthy male participants.

Timeline

Start
2018-08-14
Primary completion
2018-10-10
Completion
2018-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule — Oral
Subject MMF Unknown — Oral

Indications

No indication recorded.